Patient and graft survival following kidney transplantation in recipients with cystinosis: a cohort study

Am J Kidney Dis. 2015 Jan;65(1):172-3. doi: 10.1053/j.ajkd.2014.07.020. Epub 2014 Sep 18.

Authors

Rebecca A Spicer¹, Philip A Clayton², Steven J McTaggart³, Geoff Y Zhang⁴, Stephen I Alexander⁵

Affiliations

¹ Sydney Children's Hospital, Sydney, Australia.
² University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Camperdown, Sydney, Australia; ANZDATA, Adelaide, Australia.
³ ANZDATA, Adelaide, Australia; Royal Children's Hospital and Mater Children's Hospital, Brisbane, Australia.
⁴ Children's Hospital at Westmead, Sydney, Australia.
⁵ University of Sydney, Sydney, Australia; Children's Hospital at Westmead, Sydney, Australia. Electronic address: stephen.alexander@health.nsw.gov.au.

PMID: 25240261
DOI: 10.1053/j.ajkd.2014.07.020

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Australia / epidemiology
Cause of Death
Cohort Studies
Cysteamine / therapeutic use*
Cystine Depleting Agents / therapeutic use
Cystinosis* / complications
Cystinosis* / mortality
Cystinosis* / therapy
Female
Graft Survival
Humans
Kidney Failure, Chronic* / etiology
Kidney Failure, Chronic* / surgery
Kidney Transplantation* / adverse effects
Kidney Transplantation* / methods
Male
Nervous System Diseases / epidemiology
Nervous System Diseases / etiology*
Patient Outcome Assessment
Survival Analysis
Vascular Diseases / epidemiology
Vascular Diseases / etiology*

Substances

Cystine Depleting Agents
Cysteamine